| Year |
Citation |
Score |
| 2004 |
Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC. Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Molecular and Cellular Biology. 24: 7578-97. PMID 15314167 DOI: 10.1128/Mcb.24.17.7578-7597.2004 |
0.659 |
|
| 2004 |
Qian Y, Gatesman AS, Baisden JM, Zot HG, Cherezova L, Qazi I, Mazloum N, Lee MY, Guappone-Koay A, Flynn DC. Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity. Journal of Cellular Biochemistry. 91: 602-20. PMID 14755689 DOI: 10.1002/Jcb.10725 |
0.712 |
|
| 2002 |
Qian Y, Baisden JM, Cherezova L, Summy JM, Guappone-Koay A, Shi X, Mast T, Pustula J, Zot HG, Mazloum N, Lee MY, Flynn DC. PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments. Molecular Biology of the Cell. 13: 2311-22. PMID 12134071 DOI: 10.1091/Mbc.E01-12-0148 |
0.691 |
|
| 2001 |
Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene. 20: 6607-16. PMID 11641786 DOI: 10.1038/Sj.Onc.1204802 |
0.742 |
|
| 2001 |
Baisden JM, Qian Y, Zot HM, Flynn DC. The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene. 20: 6435-47. PMID 11607843 DOI: 10.1038/Sj.Onc.1204784 |
0.743 |
|
| 2000 |
Qian Y, Baisden JM, Zot HG, Van Winkle WB, Flynn DC. The carboxy terminus of AFAP-110 modulates direct interactions with actin filaments and regulates its ability to alter actin filament integrity and induce lamellipodia formation. Experimental Cell Research. 255: 102-13. PMID 10666339 DOI: 10.1006/Excr.1999.4795 |
0.741 |
|
| 1999 |
Qian Y, Guappone AC, Baisden JM, Hill MW, Summy JM, Flynn DC. Monoclonal antibodies directed against AFAP-110 recognize species- specific and conserved epitopes Hybridoma. 18: 167-175. PMID 10380016 |
0.671 |
|
| 1998 |
Qian Y, Baisden JM, Westin EH, Guappone AC, Koay TC, Flynn DC. Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity. Oncogene. 16: 2185-95. PMID 9619827 DOI: 10.1038/Sj.Onc.1201753 |
0.707 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Unni DK, Piper M, Moldrich RX, Gobius I, Liu S, Fothergill T, Donahoo AL, Baisden JM, Cooper HM, Richards LJ. Multiple Slits regulate the development of midline glial populations and the corpus callosum. Developmental Biology. 365: 36-49. PMID 22349628 DOI: 10.1016/J.Ydbio.2012.02.004 |
0.213 |
|
| 2009 |
Summers KM, Bokil NJ, Baisden JM, West MJ, Sweet MJ, Raggatt LJ, Hume DA. Experimental and bioinformatic characterisation of the promoter region of the Marfan syndrome gene, FBN1. Genomics. 94: 233-40. PMID 19573590 DOI: 10.1016/j.ygeno.2009.06.005 |
0.2 |
|
| 2019 |
Olson DO, Baisden JM, Groten DL, Talug C. Pursuing an Elusive Prostate Carcinoma: A Case Report Involving Multiparametric MR and CT-Guided Biopsy. Case Reports in Oncology. 12: 737-741. PMID 31616282 DOI: 10.1159/000503096 |
0.179 |
|
| 2010 |
Summers KM, Bokil NJ, Lu FT, Low JT, Baisden JM, Duffy D, Radford DJ. Mutations at KCNQ1 and an unknown locus cause long QT syndrome in a large Australian family: implications for genetic testing. American Journal of Medical Genetics. Part A. 152: 613-21. PMID 20186784 DOI: 10.1002/ajmg.a.33274 |
0.102 |
|
| 2010 |
Bokil NJ, Baisden JM, Radford DJ, Summers KM. Molecular genetics of long QT syndrome Molecular Genetics and Metabolism. 101: 1-8. PMID 20594883 DOI: 10.1016/j.ymgme.2010.05.011 |
0.067 |
|
| 2006 |
Baisden JM, Reish AG, Sheng K, Larner JM, Kavanagh BD, Read PW. Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis. International Journal of Radiation Oncology, Biology, Physics. 66: 620-5. PMID 16904845 DOI: 10.1016/J.Ijrobp.2006.05.034 |
0.057 |
|
| 2008 |
Yang W, Read PW, Mi J, Baisden JM, Reardon KA, Larner JM, Helmke BP, Sheng K. Semiconductor nanoparticles as energy mediators for photosensitizer-enhanced radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 72: 633-5. PMID 19014777 DOI: 10.1016/J.Ijrobp.2008.06.1916 |
0.057 |
|
| 2007 |
Baisden JM, Romney DA, Reish AG, Cai J, Sheng K, Jones DR, Benedict SH, Read PW, Larner JM. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors. International Journal of Radiation Oncology, Biology, Physics. 68: 1229-37. PMID 17513066 DOI: 10.1016/J.Ijrobp.2007.03.024 |
0.048 |
|
| 2008 |
Baisden J, Dunlap N, Sheng K, Larner J. Simultaneous Integrated Boost with Helical Tomotherapy can be Delivered with no Significant Increase in Dose to Surrounding Normal Tissue for Primary Brain Tumors International Journal of Radiation Oncology*Biology*Physics. 72: S536. DOI: 10.1016/J.Ijrobp.2008.06.074 |
0.045 |
|
| 2013 |
Baisden JM, Martin HP. Organ Sparing Using MRI/CT Fusion for Localized Prostate Cancer. Practical Radiation Oncology. 3: S21. PMID 24674512 DOI: 10.1016/j.prro.2013.01.071 |
0.043 |
|
| 2008 |
Baisden JM, Kahaleh M, Weiss GR, Sanfey H, Moskaluk CA, Yeaton P, de Lange EE, Rich TA. Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma. Gastrointestinal Cancer Research : Gcr. 2: 219-24. PMID 19259306 |
0.043 |
|
| 2007 |
Baisden JM, Benedict SH, Sheng K, Read PW, Larner JM. Helical TomoTherapy in the treatment of central nervous system metastasis. Neurosurgical Focus. 22: E8. PMID 17608361 DOI: 10.3171/Foc.2007.22.3.9 |
0.041 |
|
| 2007 |
Cai J, Read PW, Baisden JM, Larner JM, Benedict SH, Sheng K. Estimation of error in maximal intensity projection-based internal target volume of lung tumors: a simulation and comparison study using dynamic magnetic resonance imaging. International Journal of Radiation Oncology, Biology, Physics. 69: 895-902. PMID 17889270 DOI: 10.1016/J.Ijrobp.2007.07.2322 |
0.013 |
|
| 2011 |
Baisden JM, Sheehan J, Reish AG, McIntosh AF, Sheng K, Read PW, Benedict SH, Larner JM. Helical tomotherapy simultaneous integrated boost provides a dosimetric advantage in the treatment of primary intracranial tumors. Neurological Research. 33: 820-4. PMID 22004704 DOI: 10.1179/1743132811Y.0000000035 |
0.01 |
|
| 2009 |
Kahaleh M, Rich TA, Baisden JM. In reply Gastrointestinal Cancer Research. 3: 80. |
0.01 |
|
| Hide low-probability matches. |